Risk factors for systemic fungal infections in liver transplant recipients
- 1 May 1995
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 14 (5), 375-382
- https://doi.org/10.1007/bf02114892
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Use of amphotericin B aerosols for the prevention of pulmonary aspergillosisInfection, 1994
- Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy.Archives of Disease in Childhood, 1994
- Fungal Infections in Solid-Organ TransplantationClinical Infectious Diseases, 1993
- Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Incidence, Distribution, and Outcome of Episodes of Infection in 100 Orthotopic Liver TransplantationsMayo Clinic Proceedings, 1989
- AspergillosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Host-parasite interaction in fungal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- SELECTIVE BOWEL DECONTAMINATION TO DECREASE GRAM-NEGATIVE AEROBIC BACTERIAL AND CANDIDA COLONIZATION AND PREVENT INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1988
- METABOLIC INHIBITION OF POLYMORPHONUCLEAR LEUCOCYTES IN FULMINANT HEPATIC FAILUREThe Lancet, 1976